Προϊόντα

The STAR™ Tumor Ablation System delivers meaningful pain relief and localized tumor destruction in a single treatment, often in an outpatient setting. The STAR™ Tumor Ablation system is used for treating Metastatic Spinal Tumors with targeted RadioFrequency Ablation (t-RFA).

Expand your range of treatment options: Any patient with focalized pain from a metastatic spinal tumor may be a candidate for t-RFA, several specific patient groups will likely benefit most from the procedure.

Patients Who Benefit from RF Spine Tumor Ablation with The STAR™ Tumor Ablation System

Patients with focal pain from metastatic spinal tumor(s) may be a candidate for treatment. However, patients that are ideally suited include those with:

Radio-resistant tumors
Persistent and/or recurrent pain after radiation therapy
Posterior vertebral body tumors
Reached maximum radiation dose limit
Focalized pain preventing immobilization for treatment with palliative radiation
Cannot undergo other palliative treatments due to their concurrent systemic treatments or ongoing clinical trials
Risk of myelosuppression